Centene (CNC) Financial History
Review Centene annual and quarterly financial results, key ratios, insider transactions and SEC filing history in one chronological view. Data available from FY2008 through FY2025.
Financials
18 fiscal years, FY2008 to FY2025
Insider trades
545 trades
Risk factor changes
37 changes in the latest 10-K
Filings
Annual and quarterly reports
Compare
Side by side with another company
Centene Financial Statements
History since FY2008. Annual, in US dollars. Source: 10-K XBRL data.
Centene Revenue and Growth
Compare reported revenue and year-over-year revenue growth across available fiscal years.
Centene Income Statements
Review revenue, gross profit, operating income, net income and earnings per share.
Centene Balance Sheets
Review reported debt and book-value-based ratios where company data is available.
Centene Cash Flow Statements
Compare reported free cash flow across the available fiscal history.
Centene Financial Ratios
Compare net margin, price-to-earnings and price-to-book ratios by fiscal year.
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $126.0B | $144.5B | $154.0B | $163.1B | $194.8B |
| Revenue growth | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | +14.7% | +6.5% | +5.9% | +19.4% |
| Gross profit | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $14.5B | $16.9B | $17.6B | $17.1B | $14.2B |
| Operating income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $1.8B | $1.3B | $2.9B | $3.2B | $-7.6B |
| Net income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $1.3B | $1.2B | $2.7B | $3.3B | $-6.7B |
| Debt | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $19.0B | $18.2B | $18.0B | $18.6B | $17.5B |
| Free cash flow | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $3.3B | $5.3B | $7.3B | $-0.5B | $4.3B |
| Net margin | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 1.1% | 0.8% | 1.8% | 2.0% | -3.4% |
| EPS (diluted) | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $2.28 | $2.07 | $4.95 | $6.31 | $-13.53 |
| P/E ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 36.1× | 39.6× | 15.0× | 9.6× | n/m |
| P/B ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 1.8× | 1.9× | 1.5× | 1.1× | 1.0× |
Daily closing prices, aggregated by calendar year.
| Year | 2003 🔒 | 2004 🔒 | 2005 🔒 | 2006 🔒 | 2007 🔒 | 2008 🔒 | 2009 🔒 | 2010 🔒 | 2011 🔒 | 2012 🔒 | 2013 🔒 | 2014 🔒 | 2015 🔒 | 2016 🔒 | 2017 🔒 | 2018 🔒 | 2019 🔒 | 2020 🔒 | 2021 🔒 | 2022 | 2023 | 2024 | 2025 | 2026 (YTD) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Open | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.22 | $81.92 | $75.14 | $60.99 | $41.18 |
| Close | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.02 | $74.21 | $60.58 | $41.17 | $74.24 |
| High | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $98.52 | $83.58 | $81.40 | $66.75 | $78.13 |
| Low | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $73.20 | $60.83 | $55.03 | $23.04 | $31.64 |
| Annual return | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | -0.5% | -9.5% | -18.4% | -32.0% | +80.3% |
Centene Insider Transactions
From Form 4 filings. Showing the latest 5 of 545 trades.
| Traded | Filed | Insider | Type | Shares | Value | % of holdings |
|---|---|---|---|---|---|---|
| 2026-10-15 | 2026-10-15 | Michael Carson Group President, Medicare&Spec | Tax withholding | 7,130 | $500K | — |
| 2026-09-30 | 2026-09-30 | Lauren Tyler Director | Grant or award | 482 | — | — |
| 2026-09-30 | 2026-09-30 | Kenneth Tanji Director | Grant or award | 603 | — | — |
| 2026-09-30 | 2026-09-30 | Theodore Samuels II Director | Grant or award | 583 | — | — |
| 2026-09-30 | 2026-09-30 | Frederick Eppinger Director | Grant or award | 864 | — | — |
Centene Risk Factor Changes
Latest 10-K compared with the year before. 37 changes found.
Extended eligibility for the Enhanced APTC for Marketplace members expired on December 31, 2025.
As of December 31, 2025, we had consolidated indebtedness of $17.4 billion.
We are also subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us.
From time to time, we are a defendant in lawsuits and regulatory actions and are subject to investigations relating to our business, including, without limitation, claims that may have retroactive application and peri…
In April 2016, CMS issued final regulations that revised existing Medicaid managed care rules by establishing a minimum MLR standard for Medicaid of 85% and strengthening provisions related to network adequacy and acc…
Among the most significant of the ACA's provisions was the establishment of the Health Insurance Marketplace for individuals and small employers to purchase health insurance coverage that included a minimum level of b…
Significant changes to the ACA and the other government-sponsored healthcare programs in which we participate could materially and adversely affect our results of operations, financial condition, and cash flows.
In addition, CMS regulations will require beneficiaries dually enrolled in Medicare and in a Medicaid managed care plan to receive integrated care through the Medicaid company's Medicare Advantage D-SNPs beginning in…
Payments from government payors may be delayed in the future, which, if extended for any significant period of time, could have a material adverse effect on our results of operations, financial condition, cash flows o…
Changes in business strategy, divestitures, government regulations or economic or market conditions and non-renewal of government contracts have resulted and may result in impairments of our real estate portfolio, goo…
We are subject to risks associated with outsourcing services and functions to third-party vendors.
In addition, we are subject to certain state and federal regulations and contractual provisions regarding provider directory accuracy.
From time to time, healthcare providers assert or threaten to assert claims seeking to terminate non-cancelable agreements due to alleged actions or inactions by us.
Operations in a number of states have accounted for a significant portion of our premium revenues to date.
In addition, the IRA has substantially increased PDP's risk exposure.
We derive a portion of our cash flow and gross margin from our PDP operations, for which we submit annual bids for participation.
When our contracts with government entities expire, they may be opened for bidding by competing healthcare providers, and there is no guarantee that our contracts will be renewed or extended.
Government customers have performed and continue to perform audits of selected plans to validate the provider coding practices under the risk adjustment model used to calculate the premium paid for each member.
CMS establishes annually different pricing components of the Medicare Advantage program that may not adequately reflect changes in the underlying health care costs, and which may reduce the profitability or desirabili…
If we fail to design and maintain programs that are attractive to Medicare participants; if our Medicare operations are subject to negative outcomes from program audits, sanctions, penalties or other actions; if we do…
In the Health Insurance Marketplace, we may be adversely impacted if we have not accurately and timely predicted the health needs of our members, including individuals exiting or entering the market, causing the morbi…
Additionally, when we commence operations in a new state or region or launch a new product, we have limited information with which to estimate our medical claims liability and continuity of care requirements, which ca…
Assumptions and estimates are utilized in establishing premium deficiency reserves, when necessary.
In addition, as a result of the expiration of the public health emergency (PHE) due to the COVID-19 pandemic, and the resulting Medicaid redeterminations process, as well as changes in state benefit designs, we have c…
Our profitability depends to a significant degree on our ability to accurately estimate and effectively manage expenses related to health benefits through, among other things, our ability to contract favorably with ho…
Additionally, the U.S.
Future levels of funding and premium rates may be affected by continuing government efforts to contain healthcare costs and may further be affected by state and federal budgetary constraints and spending initiatives o…
In August 2022, the U.S.
If eligibility for the enhanced advance premium tax credit for Marketplace members expires without renewal or the eligibility for the credit is modified or delayed, our results of operations, financial condition, and…
Failure to accurately estimate and price our medical expenses or effectively manage our medical costs or related administrative costs could have a material adverse effect on our results of operations, financial condit…
We are subject to the tax laws in the U.S.
In addition, the OBBBA includes requirements that may reduce the number of members eligible for state Medicaid Expansion programs by requiring work or community engagement by members and for state Medicaid agencies to…
Medicare remains subject to the automatic spending reductions imposed by the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 (sequestration), subject to a 2% cap, which was extended by the Bipa…
Future levels of funding and premium rates may be affected by continuing government efforts to contain healthcare costs and may further be affected by state and federal budgetary constraints and spending initiatives o…
Extended eligibility for the Enhanced APTC for Marketplace members expired on December 31, 2025.
The Final Rule was published in the Federal Register on June 25, 2025.
Failure to timely and effectively identify and mitigate medical cost trends and receive adequate rate adjustments to account for increased acuity could have a material adverse effect on our results of operations, fina…
Centene SEC Filings
Latest annual and quarterly reports, current reports, proxy statements and ownership filings.
| Form | Filed | Description | Document |
|---|---|---|---|
| Current report (8-K) | 2026-10-27 | Quarterly results | View document |
| Quarterly report (10-Q) | 2026-10-27 | Quarter ended Sep 30, 2026 | View document |
| Current report (8-K) | 2026-10-08 | Other news | View document |
| Current report (8-K) | 2026-09-16 | — | View document |
| Current report (8-K) | 2026-08-17 | — | View document |
Centene financial metrics by year
Centene in the S&P 500 rankings
- #16 by revenue as of FY2025
- #61 by one-year revenue growth as of FY2025
- #91 by free cash flow as of FY2025
S&P 500 is a trademark of S&P Dow Jones Indices LLC. StockYears is not affiliated with or endorsed by S&P Dow Jones Indices.
Compare Centene with similar companies
- CNC vs CI Cigna Group
- CNC vs ELV Elevance Health
- CNC vs HUM Humana
- CNC vs UNH UnitedHealth Group